Send feedback

SPAST p.Arg7Pro

c.20G>C · rs750900931 · VCV1384983

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7099 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.000513%, nfe)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
hereditary spastic paraplegia 4

Computational evidence

Protein change
AlphaMissense0.7099likely pathogenic
REVEL0.564indeterminate
SaProtLLR -7.20tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.8GERP 2, phastCons 1
Regional constrainto/e 1.22unconstrained · MANE · 52 kb · p 3.5e-06 · regional, not allelic
Overall
CADD26.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.000513% European (non-Finnish) · 6/1,170,482 alleles
Filtering AF 0.000184% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000121%
Overall 0.000379% 6/1,581,606 alleles · very rare exomes 4/1,429,578 · genomes 2/152,028 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SPAST
Protein
p.Arg7Pro
Coding
c.20G>C
MANE Select
NM_014946
dbSNP
rs750900931
Type
single nucleotide variant
Location
chr2:32063851 (GRCh38)
Gene constraint
LOEUF 0.69 · pLI 0.11 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 77.03 · 7 PDB
Residue 7
the 'required for interaction with rtn1' region; the 'required for midbody localization' region; the 'required for interaction with atl1' region; the 'required for nuclear localization' region; the 'disordered' region
Full SPAST gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary spastic paraplegia 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Autosomal dominant spastic paraplegia type 4 (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood, Infancy
Prevalence
1-9 / 1 000 000 (Portugal)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spast-p-arg7pro (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown